BW

MLH3 (R546) polyclonal Antibody | BS2762

(No reviews yet) Write a Review
SKU:
BW-BS2762
Availability:
Usually ships in 5 working days
$1,281.00 - $1,921.50

Description

MLH3 (R546) polyclonal Antibody | BS2762 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human,Mouse,Rat

Application: WB IHC

Application Range: WB: 1:500~1:1000 IHC: 1:50~1:200

Background: DNA mismatch repair (MMR) is essential for maintaining the integrity of the genome during replication. This process is highly conserved across bacterial and eukaryotic systems, as many of the genes expressed in bacteria are closely related to the yeast and mammalian homologs. In bacteria two proteins, MutS and MutL, form homodimeric complexes that are responsible for recognizing and facilitating MMR. Human homologs of these proteins include MSH2 and MSH3 (MutS homolog 2 and 3), and the corresponding human homologs of MutL are MLH1, PMS1, PMS2 and MLH3. MSH2 and MSH3 form heterodimers that cooperatively mediate MMR. MLH3 preferentially dimerizes with MLH1 to repair DNA mismatches and restore the stability to the genome. Mutations in the genes encoding MSH2 and MLH1 induce microsatellite instablitiy of the DNA. These mutations are associated with the occurrence of hereditary nonpolyposis colorectal cancer (HNPCC) and are a common feature in the progression of many other cancers.

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: MLH3 (R546) polyclonal Antibody detects endogenous levels of MLH3 protein.

Molecular Weight: ~ 164 kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: DNA mismatch repair protein Mlh3; MutL protein homolog 3; MLH3

Immunogen: Synthetic peptide, corresponding to amino acids 513-563 of Human MLH3.

Conjugate: N/A

Modification: N/A

Purification & Purity: The Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Pathway: N/A

View AllClose